Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 73Other hematologic neoplasm 34Myeloid 12Plasma cell 11Sarcoma 6Classical hematology 4CNS 3Other solid neoplasm 1Other neoplasm 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Neuroblastoma 30Central Nervous System Neoplasms 18Brain Neoplasms 14Medulloblastoma 12Rhabdoid Tumor 8Astrocytoma 8Sarcoma 7Retinoblastoma 7Wilms Tumor 6Sarcoma, Ewing 5Rhabdomyosarcoma 5Hepatoblastoma 5Optic Nerve Glioma 4Carcinoma, Renal Cell 4Testicular Neoplasms 3Osteosarcoma 3Neuroectodermal Tumors, Primitive, Peripheral 3Neoplasms, Germ Cell and Embryonal 3Lymphoma 3Glioma 3Glioblastoma 3Familial ependymoma 3Choroid Plexus Neoplasms 3Thrombocytopenia 2Recurrence 2Pyloric Stenosis, Hypertrophic 2Pinealoma 2Pheochromocytoma 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive 2

Interventions

Filgrastim 11Temozolomide 9Melphalan 9Cyclophosphamide 9Radiotherapy 7Busulfan 7Magnetic Resonance Spectroscopy 6Rituximab 5Psychiatric Rehabilitation 5Methotrexate 5Etoposide 5Cytarabine 5Carboplatin 5sargramostim 4fludarabine 4etoposide phosphate 4Thiotepa 4Nivolumab 4Methylprednisolone 4Flow Cytometry 4Alemtuzumab 4Vincristine 3Topotecan 3Specimen Handling 3Peripheral Blood Stem Cell Transplantation 3Pemetrexed 3Granulocyte Colony-Stimulating Factor 3Early Intervention, Educational 3Drug Therapy 3Dexamethasone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lymphoma × Granulocyte Colony-Stimulating Factor × CNS × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT02933333 2018-10-17

G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase 4 Unknown
405 enrolled
CNSGastrointestinalLymphoidOther hematologic neoplasmOther solid neoplasm

Lymphoma, Neuroblastoma, Retinoblastoma, Leukemia, Myeloid, Acute, Hepatoblastoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02130869 2017-12-22

A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas

St. Jude Children's Research Hospital

Phase 1 Completed
8 enrolled
CNSLymphoid

Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡